FSD Pharma Inc.
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada. Show More...
-
Website http://www.fsdpharma.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 5.39 USD
-
Last Updated 16-10-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2011-08 2012-08 2013-08 2014-08 2015-08 2016-08 2017-08 2017-12 2018-12 2019-12 TTM Earnings Per Share CAD -0.010 -0.010 -0.54 -3.85 -7.37 -8.48 Dividends CAD Payout Ratio % * Shares Mil 7.0 7.0 7.0 7.0 6.0 7.0 9.0 Book Value Per Share * USD 7.11 5.95 3.51 Free Cash Flow Per Share * USD -0.010 -2.09 Return on Assets % -635.63 -180.87 -25.76 -68.35 -94.38 -123.42 Financial Leverage (Average) 1.1 1.03 1.19 1.17 Return on Equity % -28.39 -71.59 -104.81 -134.98 Return on Invested Capital % -28.39 -71.59 -100.13 -127.85 Interest Coverage -250.94 -202.13 Current Ratio 0.04 0.12 0.16 4.26 12.94 1.25 3.63 Quick Ratio 0.04 0.12 0.16 3.98 12.68 1.1 1.47 Debt/Equity